Top

Indian Journal of Otolaryngology and Head & Neck Surgery

Published in:

01-03-2016 | Invited Article

Genetics: A New Frontier in Otology

Authors: Mohan Kameswaran, S. Sudhamaheswari, Kiran Natarajan

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 1/2016

Abstract

Molecular genetics is a rapidly expanding field with possibilities for novel diagnostic and treatment strategies for otological diseases. Gene therapy, if theory is proven practical, could eliminate disease at the molecular level, thus obviating the need for pharmacologic or surgical treatment. Recent years have seen great advances in our understanding of the molecular genetic basis of many otological disorders. Building on the success of the Human Genome Project, new technologies are in development to identify disease-causing mutations through genetic testing. A basic understanding of the genetic basis of Otological diseases is crucial to the practising Otologist and the time has come for genetic services to be incorporated into regular Otological clinics.

Morton CC, Nance WE (2006) Newborn hearing screening: a silent revolution. N Engl J Med 354:2151–2164CrossRefPubMed

Smith RJ, BaleJ F Jr, White KR (2005) Sensorineural hearing loss in children. Lancet 365:879–890CrossRefPubMed

Marres HA (1988) Congenital abnormalities of the inner ear. In: Ludman H, Bath WT (eds) Diseases of the ear. Arnold & Oxford University Press, Oxford, pp 288–296

Friedman TB, Griffith AJ (2003) Human nonsyndromic sensorineural deafness. Annu Rev Genomics Hum Genet 4:341–402CrossRefPubMed

Kochhar A, Hildebrand MS, Smith RJ (2007) Clinical aspects of hereditary hearing loss. Genet Med 9:393–408CrossRefPubMed

Van Camp G, Willems PJ, Smith RJ (1997) Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 60:758–764PubMedPubMedCentral

ACMG (2002) Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel: ACMG statement. Genet Med 4:162–171CrossRef

Hone SW, Smith RJ (2002) Medical evaluation of pediatric hearing loss: laboratory, radiographic, and genetic testing. Otolaryngol Clin North Am 35:751–764CrossRefPubMed

Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fischel-Ghodsian N (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289–294CrossRefPubMed

10.

Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G et al (1997) Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 6628:80–83CrossRef

11.

Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR et al (1997) Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 6:2173–2177CrossRefPubMed

12.

Martin PE, Coleman SL, Casalotti SO, Forge A, Evans WH (1999) Properties of connexin26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness. Hum Mol Genet 8:2369–2376CrossRefPubMed

13.

Gasparini P, Rabionet R, Barbujani G, Melchionda S, Petersen M, Brondum-Nielsen K et al (2000) High carrier frequency of the 35delG deafness mutation in European populations. Eur J Hum Genet 8:19–23CrossRefPubMed

14.

Ahmad S, Chen S, Sun J, Lin X (2003) Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. Biochem Biophys Res Commun 307:362–368CrossRefPubMed

15.

Petit C, Levilliers J, Marlin S, Hardelin J-P (2001) Hereditary hearing loss. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) McGraw-Hill, New York, pp 6281–6328

16.

Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene(PDS). Nat Genet 17:411–422CrossRefPubMed

17.

Pryor SP, Madeo AC, Reynolds JC, Sarlis NJ, Arnos KS, Nance WE, Yang Y, Zalewski CK, Brewer CC, Butman JA, Griffith AJ (2005) SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 42:159–165CrossRefPubMedPubMedCentral

18.

Matsunaga T, Kumanomido H, Shiroma M, Goto Y, Usami S (2005) Audiological features and mitochondrial DNA sequence in a large family carrying mitochondrial A1555G mutation without use of aminoglycoside. Ann Otol Rhinol Laryngol 114:153–160CrossRefPubMed

19.

Chinnery PF, Elliott C, Green GR, Rees A, Coulthard A, Turnbull DM, Griffiths TD (2000) The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123(Pt 1):82–92CrossRefPubMed

20.

Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A et al (2011) Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 12:R89CrossRefPubMedPubMedCentral

21.

Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J 2nd, Scherer S et al (2010) Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 107:21104–21109CrossRefPubMedPubMedCentral

22.

Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W et al (2010) Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM21 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 87:90–94CrossRefPubMedPubMedCentral

23.

Usami S, Abe S, Kasai M, Shinkawa H, Moeller B, Kenyon JB, Kimberling WJ (1997) Genetic and clinical features of sensorineural hearing loss associated with the 1555 mitochondrial mutation. Laryngoscope 107:483–490CrossRefPubMed

24.

Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295–300CrossRefPubMedPubMedCentral

25.

Gubler MC (2007) Diagnosis of Alport syndrome without biopsy? Pediatr Nephrol 22:621–625CrossRefPubMed

26.

Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, El-Zir E, Loiselet J, Petit C (1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 21:363–369CrossRefPubMed

27.

Rouillon I, Marcolla A, Roux I, Marlin S, Feldmann D, Couderc R, Jonard L, Petit C, Denoyelle F, Garabédian EN, Loundon N (2006) Results of cochlear implantation in two children with mutations in the OTOF gene. Int J Pediatr Otorhinolaryngol 70:689–696CrossRefPubMed

28.

Rodríguez-Ballesteros M, Reynoso R, Olarte M, Villamar M, Morera C, Santarelli R, Arslan E, Medá C, Curet C, Völter C, Sainz-Quevedo M, Castorina P, Ambrosetti U, Berrettini S, Freil K, Tedín S, Smith J, CruzTapia M, Cavallé L, Gelvez N, Primignani P, Gómez-Rosas E, Martín M, Moreno-Pelayo MA, Tamayo M, Moreno-Barral J, Moreno F, del Castillo I (2008) A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene1 (OTOF) in subjects with nonsyndromic hearing impairment and 222 Matsunaga T: genetic testing in otology auditory neuropathy. Hum Mutat 29:823–831CrossRefPubMed

29.

Kenneson A, Van Naarden Braun K, Boyle C (2002) GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HUGE review. Genet Med 4:258–274CrossRefPubMed

30.

Cohn ES, Kelley PM (1999) Clinical phenotype and mutations in connexin 26 (DFNB1/GJB2), the most common cause of childhood hearing loss. Am J Med Genet 89:130–136CrossRefPubMed

31.

Vrabec JT (2010) Genetic investigations of Ménière’s disease. Otolaryngol Clin North Am 43(5):1121–1132CrossRefPubMed

32.

Morrison AW, Bailey ME, Morrison GA (2009) Familial Meniere’s disease: clinical and genetic aspects. J Laryngol Otol 123(1):29–37CrossRefPubMed

33.

Rye MS, Blackwell JM, Jamieson SE (2012) Genetic susceptibility to otitis media in childhood. Laryngoscope 122(3):665–675. doi:10.1002/lary.22506 CrossRefPubMed

34.

Hoya N, Okamoto Y, Kamiya K, Fujii M, Matsunaga T (2004) A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport 15:1597–1600CrossRefPubMed

35.

Okamoto Y, Hoya N, Kamiya K, Fujii M, Ogawa K, Matsunaga T (2005) Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea. Audiol Neurootol 10:220–233CrossRefPubMed

36.

Mizutari K, Matsunaga T, Kamiya K, Fujinami Y, Fujii M, Ogawa K (2008) Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction. J Neurosci Res 86:215–222CrossRefPubMed

Title: Genetics: A New Frontier in Otology
Authors: Mohan Kameswaran
S. Sudhamaheswari
Kiran Natarajan
Publication date: 01-03-2016
Publisher: Springer India
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 1/2016
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-016-0972-6

At a glance: The STEP trials

Springer Medicine

Genetics: A New Frontier in Otology

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Myxoid Chondrosarcoma of Nasomaxilloethmoid Region with Intracranial Extension

Effect of Nasal Allergy Over Spirometric Parameters: A Prospective Study

Impact of Septal Correction on the Blood Pressure of Hypertensive Patients with Deviated Nasal Septum

“Osteoclastoma of Maxilla” a Rare Case

An Unusual Case Of Inferior Turbinate Osteoma Removed Endoscopically: A Case Report

Anteriorly Based Partial Thickness Sternocleidomastoid Muscle Flap Following Parotidectomy